226 related articles for article (PubMed ID: 25815317)
1. Antibacterial activity of synthetic peptides derived from lactoferricin against Escherichia coli ATCC 25922 and Enterococcus faecalis ATCC 29212.
León-Calvijo MA; Leal-Castro AL; Almanzar-Reina GA; Rosas-Pérez JE; García-Castañeda JE; Rivera-Monroy ZJ
Biomed Res Int; 2015; 2015():453826. PubMed ID: 25815317
[TBL] [Abstract][Full Text] [Related]
2. Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Antimicrobial Activity against E. coli ATCC 11775, S. maltophilia ATCC 13636 and S. enteritidis ATCC 13076.
Huertas Méndez NJ; Vargas Casanova Y; Gómez Chimbi AK; Hernández E; Leal Castro AL; Melo Diaz JM; Rivera Monroy ZJ; García Castañeda JE
Molecules; 2017 Mar; 22(3):. PubMed ID: 28287494
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial Activity of Truncated and Polyvalent Peptides Derived from the FKCRRQWQWRMKKGLA Sequence against Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923.
Huertas NJ; Monroy ZJR; Medina RF; Castañeda JEG
Molecules; 2017 Jun; 22(6):. PubMed ID: 28613262
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Cytotoxic Effect against MDA-MB-468 and MDA-MB-231 Breast Cancer Cell Lines.
Vargas Casanova Y; Rodríguez Guerra JA; Umaña Pérez YA; Leal Castro AL; Almanzar Reina G; García Castañeda JE; Rivera Monroy ZJ
Molecules; 2017 Sep; 22(10):. PubMed ID: 28961215
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial activity of short hydrophobic and basic-rich peptides.
Chen PW; Shyu CL; Mao FC
Am J Vet Res; 2003 Sep; 64(9):1088-92. PubMed ID: 13677384
[TBL] [Abstract][Full Text] [Related]
6. Prediction of antibiotic activity and synthesis of new pentadecapeptides based on lactoferricins.
Lejon T; Stiberg T; Strøm MB; Svendsen JS
J Pept Sci; 2004 Jun; 10(6):329-35. PubMed ID: 15214437
[TBL] [Abstract][Full Text] [Related]
7. Design and activity of novel lactoferrampin analogues against O157:H7 enterohemorrhagic Escherichia coli.
Cruz J; Ortiz C; Guzmán F; Cárdenas C; Fernandez-Lafuente R; Torres R
Biopolymers; 2014 Apr; 101(4):319-28. PubMed ID: 23877962
[TBL] [Abstract][Full Text] [Related]
8. Effect of Polyvalence on the Antibacterial Activity of a Synthetic Peptide Derived from Bovine Lactoferricin against Healthcare-Associated Infectious Pathogens.
Vega Chaparro SC; Valencia Salguero JT; Martínez Baquero DA; Rosas Pérez JE
Biomed Res Int; 2018; 2018():5252891. PubMed ID: 29984236
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of a 2-arylsulphonylated tryptophan: the antibacterial activity of bovine lactoferricin peptides containing Trp(2-Pmc).
Haug BE; Andersen J; Rekdal O; Svendsen JS
J Pept Sci; 2002 Jul; 8(7):307-13. PubMed ID: 12148780
[TBL] [Abstract][Full Text] [Related]
10. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin.
Vorland LH; Ulvatne H; Andersen J; Haukland H; Rekdal O; Svendsen JS; Gutteberg TJ
Scand J Infect Dis; 1998; 30(5):513-7. PubMed ID: 10066056
[TBL] [Abstract][Full Text] [Related]
11. Simple parameterization of non-proteinogenic amino acids for QSAR of antibacterial peptides.
Lejon T; Svendsen JS; Haug BE
J Pept Sci; 2002 Jul; 8(7):302-6. PubMed ID: 12148779
[TBL] [Abstract][Full Text] [Related]
12. Comparing bacterial membrane interactions and antimicrobial activity of porcine lactoferricin-derived peptides.
Han FF; Gao YH; Luan C; Xie YG; Liu YF; Wang YZ
J Dairy Sci; 2013 Jun; 96(6):3471-87. PubMed ID: 23567049
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis and Evaluation of Branched RRWQWR-Based Peptides as Antibacterial Agents Against Clinically Relevant Gram-Positive and Gram-Negative Pathogens.
Vega SC; Martínez DA; Chalá MDS; Vargas HA; Rosas JE
Front Microbiol; 2018; 9():329. PubMed ID: 29551999
[TBL] [Abstract][Full Text] [Related]
14. Variation in antimicrobial activity of lactoferricin-derived peptides explained by structure modelling.
Farnaud S; Patel A; Odell EW; Evans RW
FEMS Microbiol Lett; 2004 Sep; 238(1):221-6. PubMed ID: 15336425
[TBL] [Abstract][Full Text] [Related]
15. Post-antibiotic effect of the antimicrobial peptide lactoferricin on Escherichia coli and Staphylococcus aureus.
Haukland HH; Vorland LH
J Antimicrob Chemother; 2001 Oct; 48(4):569-71. PubMed ID: 11581240
[TBL] [Abstract][Full Text] [Related]
16. The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin.
Strøm MB; Rekdal O; Svendsen JS
J Pept Sci; 2002 Jan; 8(1):36-43. PubMed ID: 11831560
[TBL] [Abstract][Full Text] [Related]
17. Zinc potentiates the antibacterial effects of histidine-rich peptides against Enterococcus faecalis.
Rydengård V; Andersson Nordahl E; Schmidtchen A
FEBS J; 2006 Jun; 273(11):2399-406. PubMed ID: 16704414
[TBL] [Abstract][Full Text] [Related]
18. The role of tryptophan in the antibacterial activity of a 15-residue bovine lactoferricin peptide.
Haug BE; Svendsen JS
J Pept Sci; 2001 Apr; 7(4):190-6. PubMed ID: 11354462
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of 15-residue lactoferricin derivatives.
Strøm MB; Rekdal O; Svendsen JS
J Pept Res; 2000 Nov; 56(5):265-74. PubMed ID: 11095180
[TBL] [Abstract][Full Text] [Related]
20. Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli.
Flores-Villaseñor H; Canizalez-Román A; Reyes-Lopez M; Nazmi K; de la Garza M; Zazueta-Beltrán J; León-Sicairos N; Bolscher JG
Biometals; 2010 Jun; 23(3):569-78. PubMed ID: 20195887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
